Dr. Karthik Vasudevan

Dr. Karthik Vasudevan
Interventional Cardiologist, Bangalore

MBBS, MD, DM, FICC

  • 1 Hospital
  • 12 Years Experience

Specialities

  • Interventional Cardiology

Conditions

  • Arrhythmias

  • Atherosclerosis

  • Cardiomyopathy

    • Ischemic cardiomyopathy
    • Dilated cardiomyopathy
    • Obstructive hypertrophy cardiomyopathy
    • Endomyocardial fibrosis
    • Loffler's endocarditis
    • Alcoholic cardiomyopathy
    • Arrhythmogenic right ventricular dysplasia
  • Coronary Artery Disease (CAD)

    • Chronic ischaemic heart disease
    • Atherosclerotic cardiovascular disease
    • Atherosclerotic heart disease
  • Hypertension

    • Essential (primary) hypertension
    • Arterial Hypertension
    • High blood pressure

Expertise

Education

Fellow of The Society for Cardiac Angiography and Interventions (FSCAI).

MBBS, Bangalore Medical College and Research Institute

MD, Internal medicine, Bangalore Medical College and Research Institute

DM (Cardiology), 2003, Sri Jayadeva Institute of Cardiology

Practice Information

Columbia Asia Referral Hospital, Yeshwanthpur

Columbia Asia Referral Hospital, Yeshwanthpur

26/4, Brigade Gateway, Beside Metro, Malleswaram West, Yeshwanthpur , Bangalore, Karnataka - 560055

MON - SAT

10:00 AM - 05:00 PM

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Karthik Vasudevan and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • He was the co-investigator in various multicenter randomized international trials like SPINE, PLATO, and SEPIA-ACS1 (TIMI-42)
  • Co-Investigator for a Phase III, SHINE study (DRI 5228- A Randomized Dose Ranging Study of SR123781A including Active Control, in Patients with Unstable Angina or Non-ST-segment Elevation Myocardial Infarction scheduled to undergo Percutaneous Coronary Intervention).
  • Co-Investigator for a Phase III Randomized, Comparative, Multicentric Study to evaluate safety and efficacy of Recombinant Streptokinase of BIOCON Ltd. with Streptase® in patients with acute myocardial infarction.
  • Co-Investigator for a randomised, double-blind, parallel group, Phase III, efficacy and safety study of AZD6140 Compares with Clopidogrel for prevention of Vascular Events in patients with Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO – A study of Platelet inhibition and Patient Outcomes.
  • Co-Investigator in Biomatrix E-Registry (Biosensors International Limited).
  • Co-Investigator in Superia Indian Registry.
  • Co-Investigator in Hokusai VTE- a multicentric international trial on Edoxoban in VTE ( Diachi–Sankyo).
  • He has also presented several papers at National & State Cardiological Society of India conferences. 
  • Abciximab in Acute Coronary Syndrome– SJIC Experience, @ KAPSICON 2001, Manipal, Karnataka.
  • Closure of Large PDA in infants with modified Amplatzer duct occluder- Initial Clinical Experience, @ 2003 CSI National Conference, Kolkata.
  • Successful closure of Pulmonary AV Malformation by a novel method– presented @ 2005 national CSI, Mumbai.
  • Multivessel PCI in a patient with Cardiogenic shock– presented at Midterm Interventional Council Meet 2011, Delhi.
  • Electrocardiographic localization of the occlusion site in left anterior descending coronary artery in acute anterior wall MI, @ 2002 CSI National Conference, Kochi.
  • Diagnosis & Management of Saddle thrombus- presented at 2006 National Echo Conference, Bangalore. 
  • Embolization of Catheter tip into tight left main – successful retrieval & left main angioplasty– presented at Singapore Live – Jan 2012.
  • Degenerated SVG graft filled with thrombus –sucessfully treated with M-Guard stent– TCT 2013, San Fransisco.
  • He is a member of National and State Cardiological Society of India and Indian College of Cardiology.